Integrated drug development and manufacturing solutions supporting small molecules, biologics, and advanced therapies from clinical development through commercial supply.
Our end-to-end, integrated CDMO services help biotechnology, pharmaceutical, and life sciences companies with their drug development and manufacturing journeys. From research and development to regulatory landscape support, supply chain management, and everywhere in between, our services and solutions support the entire life cycle of drug substances and drug products, from preclinical research to commercial manufacturing.
Not only is drug development time-consuming and expensive, it also comes with complex challenges from discovery to commercialization—challenges that CDMOs can help overcome.
Whether you have a small molecule, large molecule, or advanced therapy project, our flexible and scalable offerings enable you to move from molecule to medicine to market with speed and efficiency.
120+ biotech and biopharma companies have partnered with Thermo Fisher Scientific across our CDMO and CRO services on 350+ protocols
Our network of scientists, technicians, and engineers across 25 countries provide unmatched expertise
Capacity to produce 10 billion to 12 billion softgels annually, backed by a global integrated network to fulfill both large- and small-scale commercial projects
Patheon pharma services has supported 128 regulatory approvals (NDAs/BLAs) during the last five years (2019-2023).
Integrated API, OSD, sterile, and softgel capabilities addressing solubility, bioavailability, and regulatory requirements across the full lifecycle.
Cell line development, process optimization, and commercial biologics production supported by global scale and regulatory experience.
Viral vector and mRNA development and manufacturing under CGMP conditions across specialized global facilities.
Global clinical supply planning, packaging, labeling, storage, and distribution for investigational medicinal products.
Tech transfer, commercial-scale manufacturing, packaging, and serialization for global product launches.
Global regulatory services and CMC support helping with global submissions, dossier preparation, and lifecycle management from development through commercial approval.
Our flexible and scalable drug manufacturing and development services support:
Download our CDMO checklist to evaluate key considerations for launching your molecule globally—from development through commercial supply.
CDMO services include formulation development, analytical testing, process development, clinical manufacturing, commercial manufacturing, packaging, and regulatory support across the drug development lifecycle.
Evaluate regulatory experience, modality expertise, manufacturing scale, global footprint, and the ability to provide integrated end-to-end services within one CDMO network.
We support small molecules, large molecules (biologics), and advanced therapies, including viral vector, cell therapy, and mRNA development and manufacturing, from preclinical development through clinical supply and commercial production.
Single-use bioreactors provide flexibility and faster changeover for clinical-scale mammalian manufacturing. Stainless steel systems support larger volumes suitable for commercial production. Some CDMOs offer both technologies to support seamless scale-up from development to commercial supply.